55 completed, 16 recruiting, 9 terminated, 8 active not recruiting. 96 Phase 1, 35 Phase 2.
Follow Neoplasms, Fibrous Tissue: new trials by email Literature Review of Neoplasms, Fibrous Tissue trials Research Report on Neoplasms, Fibrous Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPARK UPS/MFS: Study Of BET Inhibition With ZEN003694 To Potentiate Anti-Tumor Responses With Radiotherapy To Kickstart Abscopal Effect In Metastatic Undifferentiated Pleomorphic Sarcoma (UPS) And Myxofibrosarcoma (MFS). ZEN003694, Radiation Therapy - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1 / Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 57 | 2027-05-31 | 2026-11-18 |
| A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). ST316 IV - Familial Adenomatous Polyposis (FAP) | Phase 1 | Not yet recruiting | Sapience Therapeutics | 40 | 2027-01-04 | 2026-08-12 |
| Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST | Phase 1 / Phase 2 | Recruiting | Ankit Mangla, MD | 17 | 2026-08-01 | 2026-08-11 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1) | Phase 1 / Phase 2 | Recruiting | AeRang Kim | 45 | 2026-06-01 | 2026-07-27 |
| A Study of DEG6498 in Participants With Solid Tumors DEG6498 - Malignant Neoplasms | Phase 1 | Recruiting | Degron Therapeutics Co. | 100 | 2025-11-13 | 2026-06-30 |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA BNCT, [18F]FBPA - Thoracic Solid Malignant Tumor | Phase 1 / Phase 2 | Enrolling by invitation | Stella Pharma Corporation | 30 | 2025-04-10 | 2025-11-19 |
| A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors OKN4395, Pembrolizumab, Fasting - Solid Tumours, Sarcoma | Phase 1 | Recruiting | Epkin | 146 | 2025-01-23 | 2026-06-11 |
| NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique ICG administration - Dermatofibrosarcoma Protuberans (DFSP), Skin Squamous Cell Carcinoma | Phase 1 | Not yet recruiting | The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | 592 | 2024-10-30 | 2024-09-24 |
| Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture [Step1] CNT201 First-dose, [Step1] CNT201 Low-dose, [Step1] CNT201 Intermediate-dose - Dupuytren Contracture, Dupuytren Disease of Finger | Phase 1 / Phase 2 | Recruiting | CONNEXT | 60 | 2024-07-23 | 2026-06-12 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Dedifferentiated Liposarcoma, Metastatic Leiomyosarcoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 30 | 2024-02-06 | 2026-11-16 |
| SPEARHEAD-3 Pediatric Study Afamitresgene autoleucel - Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1 / Phase 2 | Recruiting | USWM CT, LLC | 20 | 2023-09-01 | 2026-08-11 |
| Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors TNG462, Pembrolizumab - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Tango Therapeutics, Inc. | 225 | 2023-05-26 | 2026-09-08 |
| FOG-001 in Locally Advanced or Metastatic Solid Tumors FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Parabilis Medicines, Inc. | 619 | 2023-05-23 | 2026-10-07 |
| Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications BBI-355, Erlotinib, Futibatinib - Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Carcinoma | Phase 1 | Terminated | Boundless Bio, Inc. | 85 | 2023-03-24 | 2026-08-19 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 48 | 2022-07-06 | 2026-05-19 |
| Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion MRTX1719 - Mesothelioma, Non Small Cell Lung Cancer | Phase 1 | Recruiting | Bristol-Myers Squibb | 336 | 2022-06-09 | 2026-09-02 |
| Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors TNG908 - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Terminated | Tango Therapeutics, Inc. | 110 | 2022-03-23 | 2026-04-15 |
| Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) Harmonic motion imaging guided focused ultrasound (HMIgFUS), Microbubble-mediated Low Intensity Focused Ultrasound (LIFU), Microbubbles - Fibroadenoma, Breast Cancer Stage I | Phase 1 | Recruiting | Columbia University | 82 | 2022-01-19 | 2026-08-13 |
Showing 20 of 96. Sign in to see all of them.
Sarcoma (40) · Neurofibrosarcoma (35) · Histiocytoma, Malignant Fibrous (25) · Ovarian Neoplasms (23) · Leiomyosarcoma (21) · Brenner Tumor (19) · Osteosarcoma (19) · Sarcoma, Synovial (18) · Fallopian Tube Neoplasms (17) · Dermatofibrosarcoma (15) · Liposarcoma (15) · Rhabdomyosarcoma (15) · Sarcoma, Ewing (15) · Carcinoma, Ovarian Epithelial (14) · Desmoid Tumors (14)
Neoplasms by Histologic Type (96) · Neoplasms, Connective Tissue (96) · Neoplasms, Connective and Soft Tissue (95) · Neoplasms (84) · Neoplasms, Glandular and Epithelial (55) · Neoplasms by Site (53) · Neoplasms, Nerve Tissue (49) · Female Urogenital Diseases (41) · Female Urogenital Diseases and Pregnancy Complications (41) · Urogenital Diseases (41) · Nervous System Diseases (40) · Nervous System Neoplasms (39) · Urogenital Neoplasms (39) · Peripheral Nervous System Neoplasms (36)
Carboplatin (9) · Paclitaxel (9) · Taxes (6) · Cisplatin (5) · Doxorubicin (5) · Magnetic Resonance Spectroscopy (5) · pembrolizumab (5) · Bevacizumab (4) · Imatinib Mesylate (4) · Nivolumab (4) · Specimen Handling (4) · Topotecan (4) · Cyclophosphamide (3) · Docetaxel (3) · Filgrastim (3)
National Cancer Institute (NCI) (18) · Gynecologic Oncology Group (8) · Mayo Clinic (4) · Fred Hutchinson Cancer Center (3) · AeRang Kim (2) · Eli Lilly and Company (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Jonsson Comprehensive Cancer Center (2) · Memorial Sloan Kettering Cancer Center (2) · Seattle Children's Hospital (2) · St. Jude Children's Research Hospital (2) · Tango Therapeutics, Inc. (2) · Valerio Therapeutics (2) · AbbVie (1) · Ankit Mangla, MD (1)
United States (79) · France (9) · Canada (7) · United Kingdom (7) · Australia (6) · Spain (6) · Denmark (5) · Japan (5) · Italy (4) · Germany (3) · South Korea (3) · China (2) · Taiwan (2) · Belgium (1) · Hong Kong (1)
AeRang Kim, MD, PhD (3) · Peter G. Rose, MD (3) · Don Dizon (2) · Evanthia Galanis, MD (2) · Leona A. Holmberg, MD, PhD (2) · Mark Morgan (2) · Aaron H. Wolfson, MD (1) · Aaron R Weiss, DO (1) · Alba Rubio (1) · Albiruni Razak, M.D. (1) · Alice P Chen, M.D. (1)
PMID 31401903, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15592836, PMID 16412499, PMID 16631245, PMID 16959305, PMID 19088049, PMID 19671873, PMID 20622000, PMID 23382028, PMID 24089446, PMID 25858498, PMID 28341300, PMID 30410720, PMID 31386610, PMID 31708167, PMID 32089640, PMID 32554315, PMID 33203665, PMID 33610319, PMID 33641042, PMID 34321280, PMID 34814185, PMID 35260879, PMID 38579194, PMID 39255444, PMID 39356980, PMID 39756156, PMID 39956770, PMID 41836677, PMID 42874021
U10CA027469 (8), P50CA136393 (2), U10CA180868 (2), 2008 (1), 2015 (1), 2019 (1), 2023 (1), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA008748 (1), P30CA014599 (1), P30CA015083 (1), P30CA016087 (1), R01CA136547 (1)